Table 1.
Experimental model | Phenotype | Gene expression of Notch target genes | References | |
---|---|---|---|---|
Downregulation | Upregulation | |||
Villin-CreERT2; N1F/F | Increased goblet, enteroendocrine and Paneth cells. Decreased LGR5+ and EdU+ cells. Loss of Olfm4+ cells. |
Hes1, Lgr5 and Olfm4 | Math1, Ngn3, Spdef, Muc2, ChgA, Mmp7, Dll1 and Dll4 | (34) |
Villin-CreERT2; N2F/F | Unaffected goblet cells | Not reported | No changes in Atoh1, ngn3, Muc2, ChgA, Mmp7, Dll1 and Dll4 | (34) |
Notch1/Notch2lox/lox-vil-Cre-ERT2 Villin-CreERT2; N1F/F/N2F/F (N1Δ/Δ;N2Δ/Δ) |
Highly increased goblet cells. Reduced Hes1+ cells. |
Hes1 | Muc2, Atoh1, Spdef, ChgA, Mmp7, Dll1 and Dll4 | (31) (34) |
Dll1flox/flox vil-Cre-ERT2 | Increased goblet cells | Not reported | Not reported | (37) |
Dll4flox/flox vil-Cre-ERT2 | Unaffected goblet cells | Not reported | Not reported | (37) |
Dll1-Dll4vil-Cre-ERT2 | Highly increased goblet cells. Decreased Olfm4+ cells. Loss of Lgr5+, Ascl2+, Hes1+ Ki67+ cells. Inhibited NICD1 cleavage. |
Not reported | Math1 | (37) |
Villin-Cre;Adam10f/f
Villin-CreERT2;Adam10f/f or organoids from different ADAM10 mutants |
Increased goblet, Paneth, enteroendocrine and cleaved caspase-3+ cells. Decreased enterocytes, BrdU+ and Ki67+ cells. |
Hes1, HeyL and Olfm4 | Tff3, Muc2, Cryptdins, Mmp7, ChgA, Atoh1, Gfi1, Spdef, Ngn3 and Sox9 | (20) |
γ-secretase inhibitors DBZ/DAPT treatment to mice models or mouse intestinal organoid | Inhibited NICD1 expression. Increased goblet, Paneth enteroendocrine, Tuft, SOX9+ and MATH1+ cells. Decreased Ki67+ and HES1+ cells. |
Olfm4 and Ascl2 | Math1, Lysozyme, Mmp7, EphB3, Ngn3, Spdef, Gfi1, Tff3 and Prom1. | (7, 31–33, 64, 65, 78) |
RBP-Jfloxed/floxed/P450-Cre Rbpjlox/lox-vil-Cre-ERT2 RBP-Jvil-Cre-ERT2 Rbpjfl/fl:villin-creER RbpjF/F:Villin-CreERT2 |
Increased goblet cells and MATH1+ cells. Reduced HES1+ cells. Loss of Lgr5+, Olfm4+, Acl2+, Hes6+ and Ki67+ cells. |
Hes1 | Math1 | (32) (31) (37) (64) (34) |
Vil-Cre;Rosa26DN-MAML/+ | Increased goblet, Paneth and enteroendocrine cells. Decreased HES1+ and Ki67+ cells. | Not reported | Not reported | (20) |
Embryonic Hes1 KO Hes1-KO pups Villin-Cre;Hes1flox/– Hes1fl/fl Cre-ERT2 Hes1fl/flVillin-Cre |
Increased goblet, Paneth, cryptdin 4+ and cleaved caspase-3+ cells. Decreases Ki67+ cells. |
Reg3g, Saa1 and Reg3b | Math1, Lysozyme, Cryptdin 1, 4 and 5 Gast, Gcg, Smst, Cck, Sct, Tph, Gip, ChgA, Atoh1, Isl1, Nkx2–2, Pax6, Pax4, Dll1, Dll3, Hes3, Hes5, Tbp, Atoh5 and Neurod1. | (66) (67) (23) (69) (69) |
Hes5 −/− | Increased goblet cells | Not reported | Muc2, Dll1 and Fbw7β | (68) |
Villin-Cre;Hes1 flox/ ; Hes3 –/ ;Hes5 –/– | Increased goblet, Paneth, enteroendocrine and cleaved caspase-3+ cell. Decreased Ki67+ cells. |
Not reported | Not reported | (23) |
Math1β-Gal/-
Math1Δintestine/Lacz Math1LoxP/LoxP/AHCre Atoh1flox/flox:Fabp-Cre Atoh1fl/fl;villin-creER Lrig1CreERT2/+;Atoh1fl/fl |
Decreased goblet, enteroendocrine and Paneth cells. | Lack of cryptdins | Not reported | (72) (76) (65) (78) (64) (75) |
The name of each experimental mouse model is written as in the original article. The phenotype observed was based on histology, immunohistochemistry, Western analysis and flow cytometry. KO, knockout.